According to Fortune Business Insights, the global drug delivery market size stood at USD 1,021.29 billion in 2018. The market is projected to reach USD 1,801.54 billion by 2026, exhibiting a CAGR of 7.4% during the forecast period (2019–2026). North America dominated the global drug delivery market with a share of 41.91% in 2018. Increasing demand for biologics, technological advancements in medication administration, rising prevalence of chronic diseases, and growing adoption of home-based healthcare are supporting market growth.
Market Overview
The global drug delivery market is expanding as healthcare providers and pharmaceutical manufacturers increasingly adopt advanced medication administration technologies. Drug delivery systems are designed to improve drug absorption, enhance therapeutic effectiveness, and ensure accurate medication administration.
The market includes injectable, inhalation, topical and transdermal, oral, and other administration methods. These technologies are used to manage several medical conditions, including diabetes, respiratory disorders, cancer, and neurological diseases.
The growing development of biologics is encouraging pharmaceutical companies to introduce specialized delivery devices capable of administering large-volume doses. Additionally, healthcare startups are investing in innovative solutions to improve patient convenience and treatment compliance.
For detailed market insights: https://www.fortunebusinessinsights.com/drug-delivery-market-102416
Market Trends
Increasing Digitalization in Drug Delivery
Digitalization is becoming an important trend in the pharmaceutical industry. Manufacturers are integrating digital applications, medication adherence platforms, wellness technologies, and educational tools into drug delivery solutions.
Smart wearable devices are gaining popularity because they help patients administer medication conveniently and monitor treatment. For example, Insulet Corporation's Omnipod is a wearable device designed for diabetes management that offers a smart, waterproof, and discreet insulin delivery solution.
Growing Demand for Innovative Drug Delivery Products
The introduction of advanced products featuring large-volume dosing capabilities, smart technology, and user-friendly designs is supporting market growth. Products such as ocular inserts, insulin jet devices, and wearable delivery systems are attracting increasing attention.
In October 2019, West Pharmaceutical Services Inc. launched its NovaPure 3ml cartridge to support the delivery of higher-volume injectable medicines.
Increasing Adoption of Advanced Administration Systems
Patients are increasingly shifting from conventional drug dispensing methods toward advanced administration technologies. Wearables, auto-injectors, and dry powder inhalers offer portability, flexibility, and convenient self-administration.
These technologies also support self-monitoring and help improve patient adherence to prescribed treatments.
Growing Investment in Nanotechnology
Nanotechnology-based drug delivery systems are gaining attention because of their potential to support targeted medication administration. These technologies are particularly relevant to complex conditions such as cancer and neurological disorders, where precise drug delivery is important.
Market Drivers
Rising Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases is a major factor driving the drug delivery market. Conditions such as diabetes, asthma, respiratory disorders, and cancer require regular medication and effective treatment management. Advanced delivery technologies help improve dosage accuracy and patient convenience.
Increasing Demand for Biologic Drugs
Growing demand for biologics is encouraging pharmaceutical manufacturers to develop specialized drug administration devices. These medicines often require advanced delivery technologies to ensure appropriate dosage and effective treatment.
Growing Preference for Home-Based Healthcare
The increasing adoption of home-based healthcare is supporting demand for wearable and self-administration devices. Patients are increasingly interested in convenient treatment options that reduce frequent hospital visits and allow them to manage their conditions independently.
Continuous Product Innovation
Manufacturers are investing in research and development to introduce innovative drug delivery products. Advanced technologies offering large-volume dosing, improved usability, and reduced side effects are encouraging the adoption of modern medication administration systems.
However, frequent changes in regulatory guidelines for combination products create challenges for manufacturers. Stringent approval requirements and changing compliance standards can increase product development timelines and affect new product launches.
Market Segmentation
The drug delivery market is segmented by route of administration, type, distribution channel, and region.
By Route of Administration: The market is categorized into injectable, inhalation, topical and transdermal, oral, and others. The injectable segment is expected to dominate the market because of its ability to deliver medicines directly to targeted locations. Increasing preference for ready-to-use injection devices and localized treatment delivery is supporting segment growth. The topical and transdermal segment is also expected to witness significant growth because these technologies can minimize side effects, avoid first-pass metabolism, and improve patient compliance.
By Type: The market is divided into conventional and advanced drug delivery systems. Conventional drug delivery systems account for the dominant market share because of the widespread use of injections, inhalers, and nebulizers. However, the advanced segment is expected to register faster growth due to increasing investments in nanotechnology, wearable devices, and patient-friendly administration solutions.
By Distribution Channel: The market is classified into hospital pharmacies, retail pharmacies, and others. Hospital pharmacies account for the major market share, supported by increasing hospital admissions and improvements in healthcare infrastructure. Retail pharmacies are expected to emerge as the fastest-growing segment due to convenient product availability and increasing adoption of inhalers, self-injectable devices, and self-monitoring technologies.
Key Players
Major companies operating in the global drug delivery market include:
- BD
- Emergent BioSolutions Inc.
- Consort Medical plc
- Aptar Pharma
- West Pharmaceutical Services Inc.
- Insulet Corporation
- Nemera
- SHL Medical AG
- Pfizer Inc.
- 3M
These companies focus on research and development, innovative product launches, strategic collaborations, and acquisitions to strengthen their market positions.
Regional Analysis
North America: North America dominated the global drug delivery market with a 41.91% share in 2018, generating USD 428.00 billion in revenue. Favorable healthcare reimbursement policies, increasing adoption of advanced drug delivery devices, and the growing prevalence of chronic diseases supported regional growth. The presence of prominent pharmaceutical companies and increasing development of biologics further contribute to market expansion.
Europe: Europe held the second-largest position in the global market. Increasing prevalence of chronic diseases, rising adoption of advanced therapies, and the presence of multinational pharmaceutical companies in countries such as Italy, Switzerland, and Ireland are supporting regional development.
Asia Pacific: Asia Pacific is anticipated to register the highest CAGR during the forecast period. Increasing population, a large potential patient base, and growing healthcare awareness in countries such as China and India are supporting regional growth. Rising adoption of advanced medication administration technologies is also creating opportunities.
Latin America: The Latin American market is at a developing stage. However, improvements in healthcare infrastructure and increasing access to modern medical technologies are expected to support market development.
Middle East & Africa: The market is gradually expanding due to improvements in healthcare infrastructure and increasing investments in medical facilities. Better access to healthcare services is expected to create opportunities for drug delivery manufacturers.
Competitive Landscape
The global drug delivery market is fragmented, with numerous pharmaceutical and medical device manufacturers competing through technological innovation and product development. Companies are focusing on developing patient-friendly, therapeutically effective, and smart medication administration devices.
Strategic partnerships, mergers, and acquisitions are helping market participants expand their product portfolios and geographical presence.
In May 2021, Becton, Dickinson and Company announced an investment of approximately USD 200 million in a new facility in Zaragoza, Spain, to support the growth of its prefilled drug delivery business.
In May 2020, Kindeva Drug Delivery launched as an independent company following its acquisition by Altaris Capital Partners. In September 2020, Stevanato Group collaborated with Bexson Biomedical Inc. to develop a customized version of its SG EZ-be Pod wearable drug delivery device.
Future Outlook
The drug delivery market is expected to benefit from continuous advancements in pharmaceutical technologies and increasing demand for patient-friendly medication administration. Growing investments in biologics, nanotechnology, wearable devices, and smart drug delivery systems will create opportunities for industry participants.
Furthermore, the shift toward home-based healthcare and self-administration technologies is expected to influence future product development. Manufacturers are likely to focus on improving dosage accuracy, reducing side effects, and developing convenient delivery solutions.
However, regulatory complexities and the need for extensive product development and approval processes will remain important challenges for market participants.
Get a free sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/drug-delivery-market-102416
Conclusion
The global drug delivery market is evolving as pharmaceutical manufacturers increasingly focus on advanced medication administration technologies. Growing demand for biologics, rising chronic disease prevalence, digitalization, and the adoption of home-based healthcare are supporting industry development. Injectable and conventional delivery systems continue to represent important market segments, while advanced technologies such as wearables and nanotechnology-based devices are creating new growth opportunities.
Frequently Asked Questions (FAQs)
1. How big was the global drug delivery market in 2018?
The global drug delivery market was valued at USD 1,021.29 billion in 2018.
2. What is the projected market size of the drug delivery market by 2026?
The global drug delivery market is projected to reach USD 1,801.54 billion by 2026.
3. What is the CAGR of the drug delivery market?
The market is expected to grow at a CAGR of 7.4% during the forecast period from 2019 to 2026.
4. Which region dominated the global drug delivery market?
North America dominated the global drug delivery market with a 41.91% share in 2018.
5. Which segment leads the drug delivery market by route of administration?
The injectable segment is expected to dominate the market because of its ability to deliver drugs directly to targeted locations and increasing demand for ready-to-use injection devices.
What Everyone Should Know About Japan’s Market Drug Delivery Market Insights



Comments